This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Astrazeneca Ab. Active years: 2009-2013.
Location History:
- Gothenburg, SE (2009)
- Mölndal, SE (2010 - 2013)
Company Filing History:
Years Active: 2009-2013
Title: Leifeng Cheng: Innovator in Therapeutic Agents
Introduction
Leifeng Cheng is a notable inventor based in Mölndal, Sweden. He has made significant contributions to the field of therapeutic agents, holding a total of 4 patents. His work focuses on innovative compounds that have the potential to address various health issues.
Latest Patents
One of Leifeng Cheng's latest patents is titled "Isoxazol-3(2H)-one analogs as therapeutic agents." This invention relates to 4,5,6,7-tetrahydropyrrolo[3,2-c]pyridin-4-one and 4,5-dihydropyrrolo[3,2-c]pyridin-4-one compounds. These compounds are designed for use in the treatment of obesity, psychiatric, and neurological disorders. The patent also covers methods for their therapeutic use and pharmaceutical compositions containing these compounds.
Career Highlights
Leifeng Cheng is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on developing innovative solutions in the pharmaceutical industry. His research has the potential to impact the treatment of various medical conditions significantly.
Collaborations
Leifeng Cheng has collaborated with notable colleagues, including Jonas Boström and Tomas Fex. These collaborations have contributed to the advancement of his research and the development of new therapeutic agents.
Conclusion
Leifeng Cheng is a prominent inventor whose work in therapeutic agents is paving the way for new treatments in medicine. His innovative patents and collaborations highlight his commitment to improving health outcomes through scientific research.